Xuetao Shi Selected Research

Xuetao Shi Research Topics

Disease

10	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 05/2010
8	Neoplasms (Cancer) 04/2024 - 02/2012
5	Infections 03/2024 - 01/2018
4	Inflammation (Inflammations) 03/2024 - 01/2011
4	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2010
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 10/2021 - 12/2016
3	Stroke (Strokes) 12/2018 - 01/2014
3	Osteoporosis 06/2014 - 02/2009
2	Periodontitis 01/2024 - 12/2020
2	Fibrosis (Cirrhosis) 01/2024 - 01/2023
2	Wounds and Injuries (Trauma) 06/2023 - 10/2016
2	Bacterial Infections (Bacterial Infection) 01/2020 - 04/2017
2	Hypoxia (Hypoxemia) 01/2020 - 01/2020
2	Hemorrhage 11/2009 - 01/2008
1	Shock 03/2024
1	Immune System Diseases (Immune Disorders) 03/2024
1	Hypogonadism (Hypergonadotropic Hypogonadism) 03/2024
1	Pulpitis 03/2024
1	Pain (Aches) 01/2024
1	Cognitive Dysfunction 01/2024
1	Retinal Diseases 11/2023
1	Stress Fractures (Stress Fracture) 10/2023
1	Fatigue 10/2023
1	Ulcer 05/2023
1	Corneal Perforation 04/2023
1	Ischemic Stroke 01/2023
1	Liver Neoplasms (Liver Cancer) 12/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Intestinal Volvulus (Volvulus) 01/2021
1	Disease Progression 01/2021
1	Hyperkalemia 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Liver Failure 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Brain Edema (Cerebral Edema) 01/2019
1	Dehydration (Water Stress) 01/2019
1	Brain Injuries (Brain Injury) 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Hepatitis 01/2016

Drug/Important Bio-Agent (IBA)

5	HydrogelsIBA 03/2024 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2020
3	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 05/2018
3	Antimicrobial PeptidesIBA 01/2020 - 04/2017
2	tislelizumabIBA 04/2024 - 01/2022
2	sintilimabIBA 01/2024 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
2	CollagenIBA 05/2023 - 01/2023
2	hydroxide ionIBA 10/2021 - 03/2017
2	Fetal Proteins (Fetoprotein)IBA 01/2021 - 01/2016
2	Peptides (Polypeptides)IBA 01/2020 - 01/2020
2	Meloxicam (Mobic)FDA LinkGeneric 01/2020 - 05/2018
2	Biocompatible Materials (Biomaterials)IBA 05/2019 - 04/2017
2	ClusterinIBA 05/2018 - 05/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 01/2016
2	Diphosphonates (Bisphosphonates)IBA 01/2011 - 02/2009
1	Adenosine Monophosphate (AMP)IBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	TachykininsIBA 01/2024
1	NLR ProteinsIBA 01/2024
1	LipidsIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Small Interfering RNA (siRNA)IBA 01/2024
1	InflammasomesIBA 01/2024
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2024
1	Retinaldehyde (Retinal)IBA 11/2023
1	SaltsIBA 10/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	ChitosanIBA 12/2020
1	malic acid (malate)IBA 01/2020
1	MicellesIBA 01/2020
1	PolyestersIBA 01/2020
1	PolymersIBA 01/2020
1	polymethacrylic acid (PMAA)IBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	methacrylic acidIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2020
1	Collagen Type IV (Type IV Collagen)IBA 08/2019
1	tumstatin (74-98)IBA 08/2019
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 08/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Hepatitis B e AntigensIBA 01/2018
1	IntegrinsIBA 03/2017
1	Hydroxyl RadicalIBA 03/2017
1	GoldIBA 12/2016
1	Oral ContraceptivesIBA 01/2016
1	Postcoital Contraceptives (Morning After Pill)IBA 01/2016

Therapy/Procedure

5	Therapeutics 03/2024 - 06/2015
4	Electrodes (Electrode) 12/2018 - 01/2008
2	Neoadjuvant Therapy 04/2024 - 01/2022
2	Radiotherapy 06/2015 - 02/2012
1	Transplantation 03/2024
1	Hepatectomy 01/2024
1	Corneal Transplantation (Keratoplasty) 04/2023
1	Thrombolytic Therapy 01/2023
1	Immunotherapy 12/2022
1	Drug Therapy (Chemotherapy) 05/2018